The anti-inflammatory role of GPNMB is mediated by the CD44 non-kinase transmembrane glycoprotein24, which has been found to be augmented in PD patients using mass spectrometry in a combination of cohorts from a subset of the PPMI cohort and an independent data set16. Here, GPNMB is linked to Parkinson disease.